Novatek Successfully Passes Ironwood Pharmaceuticals, Inc. On Site Regulatory Audit

Novatek International is very pleased to announce that it has successfully met the compliance assessment audit requirements performed by Ironwood Pharmaceuticals, Inc. Novatek products are used at number FDA approved facilities in the US and around the world. This audit ensured that the procedures and practices used by Novatek International to...

Novatek International is very pleased to announce that it has successfully met the compliance assessment audit requirements performed by Ironwood Pharmaceuticals, Inc.  Novatek products are used at number FDA approved facilities in the US and around the world.  This audit ensured that the procedures and practices used by Novatek International to develop, test, install, and validate their mission critical regulatory software supported their cGMP laboratory and practices.

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company.

Source: ntint.com